Opioid therapy for chronic pain: Difference between revisions
(/* Recommendations for patients with chronic pain (DO NOT EDIT) {{cite web |url=http://www.guideline.gov/content.aspx?id=16313&search=opioid+therapy+guidelines |title=National Guideline Clearinghouse | VA/DoD clinical practice guideline for m...) |
(/* Recommendations for patients with chronic pain (DO NOT EDIT) {{cite web |url=http://www.guideline.gov/content.aspx?id=16313&search=opioid+therapy+guidelines |title=National Guideline Clearinghouse | VA/DoD clinical practice guideline for m...) |
||
Line 21: | Line 21: | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightGreen"|'''Obtain Comprehensive Assessment Including: History, Physical Examination, and a Review of Diagnostic Studies''' | | colspan="1" style="text-align:center; background:LightGreen"|'''Obtain Comprehensive Assessment Including: History, Physical Examination, and a Review of Diagnostic Studies''' | ||
'''1''' A comprehensive patient assessment should be completed to identify clinical conditions that may interfere with the appropriate and safe use of OT. The comprehensive assessment should include: | '''(1)''' A comprehensive patient assessment should be completed to identify clinical conditions that may interfere with the appropriate and safe use of OT. The comprehensive assessment should include: | ||
'''Medical history''' | '''Medical history''' | ||
Line 47: | Line 47: | ||
'''{2)''' Information from the pain history and physical exam should be reviewed to ensure that the patient has had an adequate therapeutic trial of non-opioid medication therapies. | '''{2)''' Information from the pain history and physical exam should be reviewed to ensure that the patient has had an adequate therapeutic trial of non-opioid medication therapies. | ||
'''(3)''' A urine drug test (UDT) (also referred to as urine drug screen [UDS]) should be used to screen for the presence of illegal drugs, unreported prescribed medication, or unreported alcohol use prior to starting therapy. [B] | '''(3)''' A urine drug test (UDT) (also referred to as urine drug screen [UDS]) should be used to screen for the presence of illegal drugs, unreported prescribed medication, or unreported alcohol use prior to starting therapy. [B] | ||
'''(4)''' Patients on chronic OT should be assessed for suicide risk at onset of therapy and regularly thereafter. High suicide risk is a relative contraindication for OT. | '''(4)''' Patients on chronic OT should be assessed for suicide risk at onset of therapy and regularly thereafter. High suicide risk is a relative contraindication for OT. | ||
'''(5)''' OT should be used only after careful consideration of the risks and benefits | |||
'''(5)''' OT should be used only after careful consideration of the risks and benefits. | |||
|- | |- | ||
|} | |} |
Revision as of 11:50, 28 November 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline for management of opioid therapy for chronic pain. Washington (DC): Department of Veterans Affairs, Department of Defense (DO NOT EDIT) [1]
Recommendations for patients with chronic pain (DO NOT EDIT) [1]
Assessment of patient |
"1. A trial of opioid therapy (OT) is indicated for a patient with chronic pain who meets all of the following criteria:
" |
"2. The ethical imperative is to provide the pain treatment with the best benefit-to-harm profile for the individual patient." |
Obtain Comprehensive Assessment Including: History, Physical Examination, and a Review of Diagnostic Studies
(1) A comprehensive patient assessment should be completed to identify clinical conditions that may interfere with the appropriate and safe use of OT. The comprehensive assessment should include: Medical history
Physical examination
Review of diagnostic studies and assessments Evaluation of occupational risks and ability to perform duty {2) Information from the pain history and physical exam should be reviewed to ensure that the patient has had an adequate therapeutic trial of non-opioid medication therapies. (3) A urine drug test (UDT) (also referred to as urine drug screen [UDS]) should be used to screen for the presence of illegal drugs, unreported prescribed medication, or unreported alcohol use prior to starting therapy. [B] (4) Patients on chronic OT should be assessed for suicide risk at onset of therapy and regularly thereafter. High suicide risk is a relative contraindication for OT. (5) OT should be used only after careful consideration of the risks and benefits. |